135 related articles for article (PubMed ID: 29626804)
1. The role of folic acid-conjugated polyglycerol coated iron oxide nanoparticles on radiosensitivity with clinical electron beam (6 MeV) on human cervical carcinoma cell line: In vitro study.
Fakhimikabir H; Tavakoli MB; Zarrabi A; Amouheidari A; Rahgozar S
J Photochem Photobiol B; 2018 May; 182():71-76. PubMed ID: 29626804
[TBL] [Abstract][Full Text] [Related]
2. Could FA-PG-SPIONs act as a hyperthermia sensitizing agent? An in vitro study.
Fakhimikabir H; Tavakoli MB; Zarrabi A; Amouheidari A; Rahgozar S
J Therm Biol; 2018 Dec; 78():73-83. PubMed ID: 30509670
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells.
Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812
[TBL] [Abstract][Full Text] [Related]
5. Application of dextran-coated iron oxide nanoparticles in enhancing the radiosensitivity of cancerous cells in radiotherapy with high-energy electron beams.
Rezaei M; Khoshgard K; Hosseinzadeh L; Haghparast A; Eivazi MT
J Cancer Res Ther; 2019; 15(6):1352-1358. PubMed ID: 31898672
[TBL] [Abstract][Full Text] [Related]
6. Targeting chemo-proton therapy on C6 cell line using superparamagnetic iron oxide nanoparticles conjugated with folate and paclitaxel.
Kang SH; Hong SP; Kang BS
Int J Radiat Biol; 2018 Nov; 94(11):1006-1016. PubMed ID: 30032692
[TBL] [Abstract][Full Text] [Related]
7. A reliable protocol for colorimetric determination of iron oxide nanoparticle uptake by cells.
Deda DK; Cardoso RM; Uchiyama MK; Pavani C; Toma SH; Baptista MS; Araki K
Anal Bioanal Chem; 2017 Nov; 409(28):6663-6675. PubMed ID: 28918472
[TBL] [Abstract][Full Text] [Related]
8. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
Rajkumar S; Prabaharan M
Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
[TBL] [Abstract][Full Text] [Related]
9. Folic acid-capped PEGylated magnetic nanoparticles enter cancer cells mostly via clathrin-dependent endocytosis.
Allard-Vannier E; Hervé-Aubert K; Kaaki K; Blondy T; Shebanova A; Shaitan KV; Ignatova AA; Saboungi ML; Feofanov AV; Chourpa I
Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1578-1586. PubMed ID: 27919801
[TBL] [Abstract][Full Text] [Related]
10. The role of iron oxide nanoparticles in the radiosensitization of human prostate carcinoma cell line DU145 at megavoltage radiation energies.
Khoei S; Mahdavi SR; Fakhimikabir H; Shakeri-Zadeh A; Hashemian A
Int J Radiat Biol; 2014 May; 90(5):351-6. PubMed ID: 24475739
[TBL] [Abstract][Full Text] [Related]
11. Radiation dose rate affects the radiosensitization of MCF-7 and HeLa cell lines to X-rays induced by dextran-coated iron oxide nanoparticles.
Khoshgard K; Kiani P; Haghparast A; Hosseinzadeh L; Eivazi MT
Int J Radiat Biol; 2017 Aug; 93(8):757-763. PubMed ID: 28452253
[TBL] [Abstract][Full Text] [Related]
12. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.
Liao Z; Wang H; Lv R; Zhao P; Sun X; Wang S; Su W; Niu R; Chang J
Langmuir; 2011 Mar; 27(6):3100-5. PubMed ID: 21341768
[TBL] [Abstract][Full Text] [Related]
13. Folate-PEG-superparamagnetic iron oxide nanoparticles for lung cancer imaging.
Yoo MK; Park IK; Lim HT; Lee SJ; Jiang HL; Kim YK; Choi YJ; Cho MH; Cho CS
Acta Biomater; 2012 Aug; 8(8):3005-13. PubMed ID: 22543005
[TBL] [Abstract][Full Text] [Related]
14. Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells.
Kumar M; Singh G; Arora V; Mewar S; Sharma U; Jagannathan NR; Sapra S; Dinda AK; Kharbanda S; Singh H
Int J Nanomedicine; 2012; 7():3503-16. PubMed ID: 22848174
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the factors affecting the photothermal therapy potential of small iron oxide nanoparticles over the 730-840 nm spectral region.
Bilici K; Muti A; Demir Duman F; Sennaroğlu A; Yağcı Acar H
Photochem Photobiol Sci; 2018 Nov; 17(11):1787-1793. PubMed ID: 30168556
[TBL] [Abstract][Full Text] [Related]
16. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
[TBL] [Abstract][Full Text] [Related]
17. Magnetofluorescent nanohybrid comprising polyglycerol grafted carbon dots and iron oxides: Colloidal synthesis and applications in cellular imaging and magnetically enhanced drug delivery.
Wen Y; Xu M; Liu X; Jin X; Kang J; Xu D; Sang H; Gao P; Chen X; Zhao L
Colloids Surf B Biointerfaces; 2019 Jan; 173():842-850. PubMed ID: 30551300
[TBL] [Abstract][Full Text] [Related]
18. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
Erdem M; Yalcin S; Gunduz U
Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842
[TBL] [Abstract][Full Text] [Related]
19. Enhanced radiosensitivity of LNCaP prostate cancer cell line by gold-photoactive nanoparticles modified with folic acid.
Changizi O; Khoei S; Mahdavian A; Shirvalilou S; Mahdavi SR; Keyvan Rad J
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101602. PubMed ID: 31734450
[TBL] [Abstract][Full Text] [Related]
20. Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells.
Pašukonienė V; Mlynska A; Steponkienė S; Poderys V; Matulionytė M; Karabanovas V; Statkutė U; Purvinienė R; Kraśko JA; Jagminas A; Kurtinaitienė M; Strioga M; Rotomskis R
Medicina (Kaunas); 2014; 50(4):237-44. PubMed ID: 25458961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
